Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.
Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page
- Check6 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check13 days agoChange DetectedThe website has updated the intervention type and posted a new estimated last update date, along with a revision to version 2.14.0, while removing previous entries related to version 2.13.3.SummaryDifference1%
- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check49 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for inquiries about joining the study and includes a reference to the Contacts and Locations section in the How to Read a Study Record.SummaryDifference2%
- Check64 days agoChange DetectedThe website has added new features for user interaction while removing detailed options for participant groups, interventions, and various data fields related to studies.SummaryDifference3%
- Check71 days agoChange DetectedSeveral key health-related resources, including MedlinePlus and NIH links, have been removed from the website.SummaryDifference0.3%
Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.